Improving the quality of cancer clinical trials workshop summary /
Saved in:
| Corporate Authors: | , , |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Washington, D.C. :
National Academies Press,
c2008.
|
| Subjects: | |
| Online Access: | An electronic book accessible through the World Wide Web; click to view |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000nam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 0000101425 | ||
| 005 | 20171002055247.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 080709s2008 dcua sb 000 0 eng d | ||
| 010 | |z 2008299448 | ||
| 020 | |z 9780309116688 | ||
| 020 | |z 0309116686 | ||
| 035 | |a (CaPaEBR)ebr10235163 | ||
| 035 | |a (OCoLC)560530759 | ||
| 040 | |a CaPaEBR |c CaPaEBR | ||
| 043 | |a n-us--- | ||
| 050 | 1 | 4 | |a RC270.8 |b .I47 2008eb |
| 082 | 0 | 4 | |a 362.196/994007 |2 22 |
| 245 | 0 | 0 | |a Improving the quality of cancer clinical trials |h [electronic resource] : |b workshop summary / |c National Cancer Policy Forum, Margie Patlack and Sharyl Nass, rapporteurs. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c c2008. | ||
| 300 | |a xii, 124 p. : |b ill. (some col.). | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. | |
| 530 | |a Also available on the World Wide Web. | ||
| 533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2013. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | |a Cancer |x Treatment |z United States. | |
| 650 | 0 | |a Clinical trials. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 700 | 1 | |a Patlak, Margie. | |
| 700 | 1 | |a Nass, Sharyl J. | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) | |
| 710 | 2 | |a Institute of Medicine (U.S.) | |
| 710 | 2 | |a ebrary, Inc. | |
| 856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10235163 |z An electronic book accessible through the World Wide Web; click to view |
| 908 | |a 170314 | ||
| 942 | 0 | 0 | |c EB |
| 999 | |c 90578 |d 90578 | ||